PROGRAMMABLE INFUSION PUMPS & CATHETERS MARKET

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. PROGRAMMABLE INFUSION PUMPS & CATHETERS MARKET Programmable infusion pumps and catheters are devices used for delivering fluids to the patient’s body in a controlled manner. The devices include safety features such as user alerts which are activated when there is a risk of adverse drug interaction, or when the pump’s parameters are set outside its specified safety limits. Infusion pumps are used for different purposes such as delivering nutrients or medications like antibiotics, chemotherapeutic drugs, analgesics, hormones such as insulin, and so on. These are generally designed for stationary use, that is along patient’s bedside in an ICU setting, however few such as the ambulatory infusion pumps, are portable. Infusion pumps are designed for specific purposes. For instance, the enteral pump is designed to deliver medication to patient’s digestive tract through tube feeding.

3. Increasing launch of novel infusion pumps is expected to boost the global programmable infusion pumps and catheters market growth over the forecast period Frequent approvals of novel infusion pumps and their launches in developed economies are expected to significantly drive the global programmable infusion pumps and catheters market growth over the forecast period. For instance, in April 2018, Smiths Group plc. launched its new product, CADD-Solis wireless infusion pump, for safe delivery of analgesics. These infusion pumps are portable and have wireless software and drug library updation facility without the need to find, plug in and update the pump personally. In April 2013, Flowonix Medical Inc., a medical device company involved in the manufacture of implantable drug delivery systems, launched the Prometra programmable intrathecal pump in the U.S. The pump is implantable and effective in delivering Infumorp (preservative free morphine) in patients undergoing treatment for chronic pain as it directly delivers the medication in the intrathecal space around the spinal cord.

4. Figure No.1: Global Programmable Infusion Pumps and Catheters Market Share, By Region (%), 2018 - 2026 Source: Coherent Market Insights Analysis (2017)

5. Company strategies such as acquiring funding for research and product launches, are expected to have a positive impact on global programmable infusion pumps and catheters market growth. Key players are involved in research and development of new products, which is expected to aid in growth of the market. For instance, in March 2017, Ivenix, Inc., a medical technology company involved in development of next generation infusion systems, raised US$ 50 million. Novel programmable infusion pumps have been granted approval by regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Commission (EC), Therapeutic Goods Administration (TGA), and others.. received CE approval for its Evo IQ Infusion System, a programmable volumetric infusion pump, and marketing approval from the Therapeutic Goods Administration (TGA) in Australia. The Evo IQ Infusion System consists of a software for dose error reduction and an advanced drug library to promote patient safety. Such product launches are expected to boost the global programmable infusion pumps and catheters market growth during the forecast period.

6. Increasing technological advancements in endotracheal tubes is • expected to drive the market growth over the forecast period Manufacturers are focusing on development of innovative endotracheal tubes in order to prevent the hospital acquired infections. For instance, In February, N8 Medical, LLC submitted the Investigational Device Exemption (IDE) to the Food and Drug Administration (FDA) for the first-in-human clinical study of its CeraShield Endotracheal Tube (ETT). The objective of the clinical study is to evaluate the safety and efficacy of the CeraShield Endotracheal Tube (ETT). However, increasing prevalence of hospital acquired infections such as ventilator associated pneumonia is expected to hinder the endotracheal tube market growth over the forecast period. For instance, according to the National Center for Biotechnology Information, in November 2017, each year in the U.S. ventilator-associated pneumonia (VAP) incidence range from 2 to 16 episodes per 1,000 ventilator-days.

7. Figure No.2: Global Programmable Infusion Pumps and Catheters Market Size (US$ Mn) Analysis and Forecast and Y-o-Y Growth (%) However, high costs of programmable infusion pumps and catheters is a major concern (in regions with underdeveloped reimbursement facilities) in the healthcare system, and is expected to restrain the global programmable infusion pumps and catheters market growth over the forecast period. Furthermore, efficient technicians are needed for monitoring of infusion parameters available in the programmable device. These factors are expected to restrain the global programmable infusion pumps and catheters market growth over the forecast period.

8. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. •  What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

9. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • CMI Services • CMI Latest Insights • CMI Blogs

10. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

11. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/